High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.
Publication
, Journal Article
Lai, R; Bartlett, NL; Mackey, JR; Jung, S-H; Johnson, JL; Cook, JR; Jones, D; Cass, CE; Young, JD; Said, J; Cheson, B; Hsi, ED
Published in: Leuk Lymphoma
June 2008
Duke Scholars
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
June 2008
Volume
49
Issue
6
Start / End Page
1202 / 1205
Location
United States
Related Subject Headings
- Vinorelbine
- Vinblastine
- Treatment Failure
- Survival Rate
- Reed-Sternberg Cells
- Neoplasm Recurrence, Local
- Middle Aged
- Male
- Liposomes
- Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lai, R., Bartlett, N. L., Mackey, J. R., Jung, S.-H., Johnson, J. L., Cook, J. R., … Hsi, E. D. (2008). High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study. Leuk Lymphoma, 49(6), 1202–1205. https://doi.org/10.1080/10428190802094237
Lai, Raymond, Nancy L. Bartlett, John R. Mackey, Sin-Ho Jung, Jeffrey L. Johnson, James R. Cook, Dan Jones, et al. “High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.” Leuk Lymphoma 49, no. 6 (June 2008): 1202–5. https://doi.org/10.1080/10428190802094237.
Lai R, Bartlett NL, Mackey JR, Jung S-H, Johnson JL, Cook JR, et al. High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study. Leuk Lymphoma. 2008 Jun;49(6):1202–5.
Lai, Raymond, et al. “High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.” Leuk Lymphoma, vol. 49, no. 6, June 2008, pp. 1202–05. Pubmed, doi:10.1080/10428190802094237.
Lai R, Bartlett NL, Mackey JR, Jung S-H, Johnson JL, Cook JR, Jones D, Cass CE, Young JD, Said J, Cheson B, Hsi ED. High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study. Leuk Lymphoma. 2008 Jun;49(6):1202–1205.
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
June 2008
Volume
49
Issue
6
Start / End Page
1202 / 1205
Location
United States
Related Subject Headings
- Vinorelbine
- Vinblastine
- Treatment Failure
- Survival Rate
- Reed-Sternberg Cells
- Neoplasm Recurrence, Local
- Middle Aged
- Male
- Liposomes
- Immunology